Jhimli Mitra

Title: Jhimli Mitra: Innovator in Brain Tumor Imaging Technology

Introduction

Jhimli Mitra is a notable inventor based in Cleveland, OH, who has made significant contributions to the field of medical imaging, particularly in the diagnosis and treatment of brain tumors. His innovative work focuses on enhancing the understanding of glioblastoma multiforme (GBM) through advanced imaging techniques.

Latest Patents

Mitra holds a patent for a groundbreaking invention titled "Quantifying mass effect deformation with structural radiomics in brain tumor patients." This patent describes methods and apparatuses that quantify mass effect deformation in diagnostic images of patients with GBM. The invention includes an image acquisition circuit that captures images of tissue regions affected by GBM pathology. It also features a delineation circuit that segments the tumor region from the acquired image, a pre-processing circuit that generates a pre-processed image, and a registration circuit that aligns the pre-processed image with a template image of a healthy brain. Furthermore, a deformation quantification circuit computes differences between the positions of brain sub-structures in the registered image and the template image. The invention may also include a classification circuit that categorizes the tissue region based on survival predictions.

Career Highlights

Jhimli Mitra is affiliated with Case Western Reserve University, where he continues to advance research in medical imaging and radiomics. His work is pivotal in improving diagnostic accuracy and treatment planning for patients suffering from brain tumors.

Collaborations

Mitra collaborates with esteemed colleagues such as Anant Madabhushi and Gavin Hanson, who contribute to the interdisciplinary approach of his research.

Conclusion

Jhimli Mitra's innovative contributions to brain tumor imaging technology exemplify the impact of research and invention in the medical field. His patent not only enhances diagnostic capabilities but also holds the potential to improve patient outcomes in the fight against glioblastoma multiforme.